Metrovacesa Beheer

Beheer criteriumcontroles 4/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Jorge de Leza Eguiguren

Algemeen directeur

€1.4m

Totale compensatie

Percentage CEO-salaris	46.9%
Dienstverband CEO	8yrs
Eigendom CEO	n/a
Management gemiddelde ambtstermijn	8.6yrs
Gemiddelde ambtstermijn bestuur	7yrs

Recente managementupdates

Recent updates

Estimating The Fair Value Of Metrovacesa S.A. (BME:MVC)

Sep 12

We Think Metrovacesa's (BME:MVC) Profit Is Only A Baseline For What They Can Achieve

Aug 01

If You Had Bought Metrovacesa's (BME:MVC) Shares A Year Ago You Would Be Down 24%

Dec 14

Analyse CEO-vergoeding

Hoe is Jorge de Leza Eguiguren's beloning veranderd ten opzichte van Metrovacesa's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Jun 30 2024	n/a	n/a	€18m
Mar 31 2024	n/a	n/a	-€15m
Dec 31 2023	€1m	€650k	-€21m
Sep 30 2023	n/a	n/a	-€68m
Jun 30 2023	n/a	n/a	-€71m
Mar 31 2023	n/a	n/a	-€38m
Dec 31 2022	€1m	n/a	-€23m

Compensatie versus markt: De totale vergoeding ($USD 1.45M ) Jorge } is ongeveer het gemiddelde voor bedrijven van vergelijkbare omvang in de Spanish markt ($USD 1.67M ).

Compensatie versus inkomsten: De vergoeding van Jorge is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.

CEO

Jorge de Leza Eguiguren (56 yo)

8yrs

Tenure

€1,385,000

Compensatie

Mr. Jorge Perez de Leza Eguiguren serves as Chief Executive officer at Metrovacesa, S.A. and has been its Executive Director Since November 22, 2016. Mr. Eguiguren served as Managing Director, Central & Ea...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Jorge de Leza Eguiguren	CEO & Executive Director	no data	€1.39m	geen gegevens
Borja Tejada Rendón-Luna	Chief Financial Officer	8yrs	geen gegevens	geen gegevens
Eduardo Orgaz	Chief Operating Officer	no data	geen gegevens	geen gegevens
Miguel Melero Puerta	Director of People	no data	geen gegevens	geen gegevens
Juan Carlos Mateos	Director of Strategy & Investor Relations	no data	geen gegevens	geen gegevens
Pilar Martín Bolea	Head of Legal	8.6yrs	geen gegevens	geen gegevens
Raquel Bueno Montávez	Head of Corporate Development & ESG	8.1yrs	geen gegevens	geen gegevens
Carmen Sanz Bachiller	Marketing & Innovation Director	no data	geen gegevens	geen gegevens
A. Arteaga	Head of Building & Maintenance	no data	geen gegevens	geen gegevens
Carlos García León	Managing Director	11.7yrs	geen gegevens	geen gegevens
Lucas Iturmendi	Secretary	15.7yrs	geen gegevens	geen gegevens

8.6yrs

Gemiddelde duur

57yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van MVC is doorgewinterd en ervaren (gemiddelde ambtstermijn van 8.6 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Jorge de Leza Eguiguren	CEO & Executive Director	8yrs	€1.39m	geen gegevens
Ignacio Moreno Martinez	Independent Chairman of the Board	12.1yrs	€265.00k	geen gegevens
Azucena Viñuela Hernández	Independent Director	2.8yrs	€110.00k	geen gegevens
Emma Alonso	Independent Director	6.8yrs	€110.00k	geen gegevens
Beatriz Puente Ferreras	Independent Director	6.8yrs	€100.00k	geen gegevens
Carlos Manzano Cuesta	Proprietary Director	7.2yrs	geen gegevens	geen gegevens
Ana Bolado Valle	Proprietary Director	7.4yrs	€85.00k	geen gegevens
Mariano Olmeda Sarrión	Vice President of the Board	7.6yrs	€85.00k	geen gegevens
Cesáreo Rey-Baltar Oramas	Proprietary Director	7.7yrs	geen gegevens	geen gegevens
Vicente Moreno García-Mansilla	Independent Director	6.8yrs	€100.00k	geen gegevens
Enrique Pelaez	Proprietary Director	3.8yrs	geen gegevens	geen gegevens
Juan Antonio Diez	Proprietary Director	less than a year	€7.00k	geen gegevens

7.0yrs

Gemiddelde duur

59.5yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van MVC wordt beschouwd als ervaren (gemiddelde ambtstermijn 7 jaar).

Metrovacesa Beheer

Beheer criteriumcontroles 4/4

Belangrijke informatie

Recente managementupdates

Metrovacesa S.A., Annual General Meeting, Apr 30, 2024

Less than half of directors are independent

Less than half of directors are independent

Metrovacesa S.A., Annual General Meeting, May 03, 2022

Recent updates

Estimating The Fair Value Of Metrovacesa S.A. (BME:MVC)

Now 21% undervalued after recent price drop

We Think Metrovacesa's (BME:MVC) Profit Is Only A Baseline For What They Can Achieve

New minor risk - Share price stability

Is Now An Opportune Moment To Examine Metrovacesa S.A. (BME:MVC)?

Metrovacesa S.A. to Report First Half, 2024 Results on Jul 24, 2024

Price target increased by 9.6% to €8.42

A Look At The Intrinsic Value Of Metrovacesa S.A. (BME:MVC)

Upcoming dividend of €0.36 per share

We Think Metrovacesa (BME:MVC) Can Stay On Top Of Its Debt

Is Now An Opportune Moment To Examine Metrovacesa S.A. (BME:MVC)?

Metrovacesa S.A., Annual General Meeting, Apr 30, 2024

Metrovacesa S.A. to Report Fiscal Year 2023 Results on Feb 28, 2024

A Look At The Fair Value Of Metrovacesa S.A. (BME:MVC)

Inaugural dividend of €0.33 per share

Does Metrovacesa (BME:MVC) Have A Healthy Balance Sheet?

Metrovacesa S.A. to Report Q3, 2023 Results on Oct 25, 2023

Metrovacesa S.A. to Report First Half, 2023 Results on Jul 26, 2023

These 4 Measures Indicate That Metrovacesa (BME:MVC) Is Using Debt Extensively

Is Now An Opportune Moment To Examine Metrovacesa S.A. (BME:MVC)?

Inaugural dividend of €0.33 per share

Estimating The Intrinsic Value Of Metrovacesa S.A. (BME:MVC)

Does Metrovacesa (BME:MVC) Have A Healthy Balance Sheet?

Consensus EPS estimates fall by 14%

Less than half of directors are independent

Investor sentiment improved over the past week

Is It Too Late To Consider Buying Metrovacesa S.A. (BME:MVC)?

Less than half of directors are independent

FCyC, S.L. completed the acquisition of a 11.47% stake in Metrovacesa S.A. (BME:MVC) for approximately €130 million.

Metrovacesa S.A. to Report Q3, 2022 Results on Oct 27, 2022

FCyC, S.L. cancelled the acquisition of an additional 24% stake in Metrovacesa S.A. (BME:MVC).

Estimating The Intrinsic Value Of Metrovacesa S.A. (BME:MVC)

Inaugural dividend of €0.60 per share

Metrovacesa S.A. to Report Q1, 2022 Results on May 04, 2022

Metrovacesa S.A., Annual General Meeting, May 03, 2022

Investor sentiment improved over the past week

Metrovacesa's (BME:MVC) Strong Earnings Are Of Good Quality

Metrovacesa S.A. to Report Fiscal Year 2021 Results on Feb 25, 2022

Would Metrovacesa (BME:MVC) Be Better Off With Less Debt?

Forecast breakeven date pushed back to 2022

Upcoming dividend of €0.40 per share

Does Metrovacesa (BME:MVC) Have A Healthy Balance Sheet?

Is Metrovacesa S.A. (BME:MVC) Worth €6.7 Based On Its Intrinsic Value?

Price target decreased to €7.81

Upcoming dividend of €0.40 per share

Is Metrovacesa (BME:MVC) Using Too Much Debt?

Is Metrovacesa S.A. (BME:MVC) A Strong Dividend Stock?

Metrovacesa (BME:MVC) Share Prices Have Dropped 51% In The Last Three Years

Revenue and earnings miss expectations

New 90-day low: €6.03

Loss-Making Metrovacesa S.A. (BME:MVC) Set To Breakeven

When Should You Buy Metrovacesa S.A. (BME:MVC)?

A Look At The Fair Value Of Metrovacesa S.A. (BME:MVC)

If You Had Bought Metrovacesa's (BME:MVC) Shares A Year Ago You Would Be Down 24%

New 90-day high: €6.51

Revenue misses expectations

New 90-day low: €4.81

Price target lowered to €8.09

New 90-day low: €5.17

Metrovacesa S.A. (BME:MVC) made an offer to acquire remaining 0.03% stake in Metrovacesa Promoción Y Arrendamiento S.A. for €0.09 million.

New 90-day low: €5.70

New 90-day high - €6.84

Price target raised to €10.87

Analyse CEO-vergoeding

CEO

Tenure

Compensatie

Leiderschapsteam

Gemiddelde duur

Gemiddelde leeftijd

Bestuursleden